Clinical trial
Comparative Cohort Study on the Outcome of Patients With Normal and Reduced Acetylsalicylic Acid Responsiveness Undergoing Coronary Artery Bypass Surgery
NCT01174862 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Cohort Study on the Outcome of Patients With Normal and Reduced Acetylsalicylic Acid Responsiveness Undergoing Coronary Artery Bypass Surgery
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- June 30, 2013
- Enrollment
- 304 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antithrombotic drugs [platelet-aggregation inhibitors] causing adverse effects in therapeutic use, coronary artery bypass graft triple vessel, myocardial ischemia, thrombosis